Vector Solutions: How Viral Vector CDMO Services Are Enabling Gene Therapy Advances
The Oncolytic Virus CDMO Services Market is experiencing robust growth as viral vector CDMO services continue to enable gene therapy advances and innovative cancer treatments. According to market reports, the global Oncolytic Virus CDMO Services Market was valued at USD 2,400 million in 2024 and is projected to reach USD 6.5 billion by 2035, exhibiting a CAGR of 9.6% during the...
0 Comentários 0 Compartilhamentos 169 Visualizações 0 Anterior